Filing Flows › Comparisons › ABBV vs ABT
AbbVie vs Abbott Laboratories: ABBV and ABT compared
AbbVie is the larger company: $17.4B of revenue in its latest quarter (Q3 2026) against $13.0B for Abbott Laboratories (Q3 2026). Abbott Laboratories is growing faster (+14% against +10% a year earlier). AbbVie is more profitable, with an operating margin of 36.0% against 10.4%.
Where the money goes: ABBV and ABT
AbbVie (ABBV) · Q3 2026
AbbVie, Q3 2026: revenue $17.4B (+10% year over year), operating margin 36.0%, net earnings $4.2B, operating cash flow $7.6B. The chart follows the revenue to costs, profit and cash.
Abbott Laboratories (ABT) · Q3 2026
Abbott Laboratories, Q3 2026: revenue $13.0B (+14% year over year), operating margin 10.4%, net earnings $920M, operating cash flow $1.7B. The chart follows the revenue to costs, profit and cash.
| AbbVie (ABBV) | Abbott Laboratories (ABT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $17.4B | $13.0B |
| Revenue growth, Y/Y | +10% | +14% |
| Operating margin | 36.0% | 10.4% |
| Net earnings | $4.2B | $920M |
| Net margin | 24.2% | 7.1% |
| Operating cash flow | $7.6B | $1.7B |
| Free cash flow | $7.3B | $1.2B |
| Market value | $516.2B | $197.4B |
| P/E | 50.1× | 42.4× |
| Analysts’ mean target | $310.65 | $118.52 |
Questions
Which is bigger, AbbVie or Abbott Laboratories?
AbbVie is the larger company: $17.4B of revenue in its latest quarter (Q3 2026) against $13.0B for Abbott Laboratories (Q3 2026).
Is AbbVie or Abbott Laboratories growing faster?
Abbott Laboratories is growing faster (+14% against +10% a year earlier).
Which is more profitable, AbbVie or Abbott Laboratories?
AbbVie is more profitable, with an operating margin of 36.0% against 10.4%.
More: AbbVie earnings · how AbbVie makes money · Abbott Laboratories earnings · how Abbott Laboratories makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.